Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Martin Watterson

Showing results (61-70 of 80) with videos related to

Pageof 8
Sort By:
Bioorganic & Medicinal Chemistry Letters|November 3, 2006
Development of a novel therapeutic suppressor of brain proinflammatory cytokine up-regulation that attenuates synaptic dysfunction and behavioral deficitsWenhui Hu, Hantamalala Ralay Ranaivo, Saktimayee M Roy, et al.
American Journal of Respiratory Cell and Molecular Biology|January 17, 2014
Nonmuscle myosin light chain kinase regulates murine asthmatic inflammationTing Wang, Liliana Moreno-Vinasco, Shwu-Fan Ma, et al.
Journal of Neuroinflammation|September 6, 2007
A novel p38 alpha MAPK inhibitor suppresses brain proinflammatory cytokine up-regulation and attenuates synaptic dysfunction and behavioral deficits in an Alzheimer's disease mouse modelLenka Munoz, Hantamalala Ralay Ranaivo, Saktimayee M Roy, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 28, 2012
Early stage drug treatment that normalizes proinflammatory cytokine production attenuates synaptic dysfunction in a mouse model that exhibits age-dependent progression of Alzheimer's disease-related pathologyAdam D Bachstetter, Christopher M Norris, Pradoldej Sompol, et al.
Nature Communications|April 2, 2022
PI3Kγ stimulates a high molecular weight form of myosin light chain kinase to promote myeloid cell adhesion and tumor inflammationMichael C Schmid, Sang Won Kang, Hui Chen, et al.
The Journal of Clinical Investigation|September 27, 2005
Epithelial myosin light chain kinase-dependent barrier dysfunction mediates T cell activation-induced diarrhea in vivoDaniel R Clayburgh, Terrence A Barrett, Yueming Tang, et al.
Journal of Medicinal Chemistry|January 25, 2002
Discovery of a 3-amino-6-phenyl-pyridazine derivative as a new synthetic antineuroinflammatory compoundSalida Mirzoeva, Anu Sawkar, Magdalena Zasadzki, et al.
Epilepsia|May 25, 2007
Glial activation links early-life seizures and long-term neurologic dysfunction: evidence using a small molecule inhibitor of proinflammatory cytokine upregulationKathleen C Somera-Molina, Beverley Robin, Cherie Ann Somera, et al.
EMBO Molecular Medicine|September 9, 2025
Identification of p38 MAPK inhibition as a neuroprotective strategy for combinatorial SMA therapyMaria J Carlini, Jorge Espinoza-Derout, Meaghan Van Alstyne, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 6, 2003
Protein kinase involved in lung injury susceptibility: evidence from enzyme isoform genetic knockout and in vivo inhibitor treatmentMark S Wainwright, Janet Rossi, James Schavocky, et al.
Pageof 8

Showing results (61-70 of 80) with videos related to

Sort By:
Pageof 8
Bioorganic & Medicinal Chemistry Letters|November 3, 2006
Development of a novel therapeutic suppressor of brain proinflammatory cytokine up-regulation that attenuates synaptic dysfunction and behavioral deficitsWenhui Hu, Hantamalala Ralay Ranaivo, Saktimayee M Roy, et al.
American Journal of Respiratory Cell and Molecular Biology|January 17, 2014
Nonmuscle myosin light chain kinase regulates murine asthmatic inflammationTing Wang, Liliana Moreno-Vinasco, Shwu-Fan Ma, et al.
Journal of Neuroinflammation|September 6, 2007
A novel p38 alpha MAPK inhibitor suppresses brain proinflammatory cytokine up-regulation and attenuates synaptic dysfunction and behavioral deficits in an Alzheimer's disease mouse modelLenka Munoz, Hantamalala Ralay Ranaivo, Saktimayee M Roy, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 28, 2012
Early stage drug treatment that normalizes proinflammatory cytokine production attenuates synaptic dysfunction in a mouse model that exhibits age-dependent progression of Alzheimer's disease-related pathologyAdam D Bachstetter, Christopher M Norris, Pradoldej Sompol, et al.
Nature Communications|April 2, 2022
PI3Kγ stimulates a high molecular weight form of myosin light chain kinase to promote myeloid cell adhesion and tumor inflammationMichael C Schmid, Sang Won Kang, Hui Chen, et al.
The Journal of Clinical Investigation|September 27, 2005
Epithelial myosin light chain kinase-dependent barrier dysfunction mediates T cell activation-induced diarrhea in vivoDaniel R Clayburgh, Terrence A Barrett, Yueming Tang, et al.
Journal of Medicinal Chemistry|January 25, 2002
Discovery of a 3-amino-6-phenyl-pyridazine derivative as a new synthetic antineuroinflammatory compoundSalida Mirzoeva, Anu Sawkar, Magdalena Zasadzki, et al.
Epilepsia|May 25, 2007
Glial activation links early-life seizures and long-term neurologic dysfunction: evidence using a small molecule inhibitor of proinflammatory cytokine upregulationKathleen C Somera-Molina, Beverley Robin, Cherie Ann Somera, et al.
EMBO Molecular Medicine|September 9, 2025
Identification of p38 MAPK inhibition as a neuroprotective strategy for combinatorial SMA therapyMaria J Carlini, Jorge Espinoza-Derout, Meaghan Van Alstyne, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 6, 2003
Protein kinase involved in lung injury susceptibility: evidence from enzyme isoform genetic knockout and in vivo inhibitor treatmentMark S Wainwright, Janet Rossi, James Schavocky, et al.
Pageof 8